The vagus nerve, macrophages, and nicotine

Lancet

Volumn 361, Issue 9363, 2003, Pages 1069-1070

  Floto, R Andres ^a   Smith, Kenneth G C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NICOTINE; NICOTINIC RECEPTOR; PRECIPITIN; RECEPTOR SUBUNIT; TUMOR NECROSIS FACTOR ALPHA;

ACUPUNCTURE; ALLERGIC PNEUMONITIS; CELL ACTIVATION; CELL PROLIFERATION; CIGARETTE SMOKING; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GUINEA PIG; HUMAN; IMMUNOMODULATION; INFLAMMATION; LUNG GRANULOMATOSIS; MACROPHAGE; NERVE DEGENERATION; NERVE STIMULATION; NEUROIMMUNOLOGY; NONHUMAN; NOTE; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS; TUBERCULOSIS; VAGUS NERVE;

EID: 0037471783     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12902-9     Document Type: Note

References (15)

1. Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature. 421:2003;384-388.
2. Borovikova L., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 405:2000;458-462.
3. Son Y.S., Park H.J., Kwon O.B., et al. Antipyretic effects of acupuncture on the lipopolysaccharide-induced fever and expression of interleukin-6 and interleukin-1 beta mRNAs in the hypothalamus of rats. Neurosci Lett. 319:2002;45-48.
4. Mori H., Nishijo K., Kawamura H., Abo T. Unique immunomodulation by electro-acupuncture in humans possibly via stimulation of the autonomic nervous system. Neurosci Lett. 320:2002;21-24.
5. Wilson C.J., Finch C.E., Cohen H.J. Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. 50:2002;2041-2056.
6. Sopori M. Effects of cigarette smoke on the immune system. Nature Rev Immunol. 2:2002;372-377.
7. Vassallo R., Ryu J.H., Colby T.V., et al. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 342:2000;1969-1978.
8. Hance A.J., Basset F., Saumon G., et al. Smoking and interstitial lung disease: the effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann NY Acad Sci. 465:1986;643-656.
9. Baur X., Richter G., Pethran A., et al. Increased prevalence of IgG-induced sensitization and hypersensitivity pneumonitis (humidifier lung) in nonsmokers exposed to aerosols of a contaminated air conditioner. Respiration. 59:1992;211-214.
10. Cormier Y., Gagnon L., Berube-Genest F., Fournier M. Sequential bronchoalveolar lavage in experimental extrinsic allergic alveolitis: the influence of cigarette smoking. Am Rev Respir Dis. 137:1988;1104-1109.
11. Camarena A., Juarez A., Mejia M., et al. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med. 163:2001;1513-1514.
12. Grutters J.C., Sato H., Pantelidis P., et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med. 165:2002;1119-1124.
13. Baughman R.P., Lower E.E. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 18:2001;70-74.
14. Gardam M.A., Keystone E.C., Menzies R., et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis. 3:2003;148-155.
15. Kolappan C., Gopi P.G. Tobacco smoking and pulmonary tuberculosis. Thorax. 57:2002;964-966.